Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori;Le lymphome gastrique du MALT, une infection maligne potentiellement curable par l'éradication de Helicobacter pylori

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 3 II, 2003, Pages 453-458

  Delchier, Jean Charles ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; B LYMPHOCYTE; BACTERIAL INFECTION; CANCER GENETICS; CANCER GRADING; CANCER PREVENTION; CANCER RISK; DISEASE ASSOCIATION; ECHOGRAPHY; ERADICATION THERAPY; EVALUATION; FOLLOW UP; GENE FUSION; HELICOBACTER PYLORI; HUMAN; LYMPH NODE; PATHOPHYSIOLOGY; PREVALENCE; REMISSION; REVIEW; STOMACH LYMPHOMA;

ENDOSCOPY, GASTROINTESTINAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MONITORING, PHYSIOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 0037363813     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410-6.
2. Isaacson PG, Spencer J, Wright DH. Classifying primary gut lymphomas. Lancet 1988;2:1148-9.
3. Isaacson PG. Lymphomas of mucosa-associated lymphoid tissue (MALT). Histopathology 1990;16:617-9.
4. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
5. Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992;339:834-5.
6. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
7. Zucca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998;338:804-10.
8. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-4.
9. Delchier JC, Lamarque D, Levy M, Tkoub EM, Copie-Bergman C, Deforges L et al. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. Am J Gastroenterol 2001;96:2324-8.
10. D'Elios MM, Amedei A, Manghetti M, Costa F, Baldari CT, Quazi AS et al. Impaired T-cell regulation of B-cell growth in Helicobacter pylori-related gastric low-grade MALT lymphoma. Gastroenterology 1999;117:1105-12.
11. Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002;3:97-104.
12. Du MQ. Molecular Biology of Gastric MALT Lymphoma: Application in Clinical Management. Hematology 2002;7:339-44.
13. Motegi M, Yonezumi M, Suzuki H, Suzuki R, Hosokawa Y, Hosaka S et al. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000;156:807-12.
14. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000;156:1183-8.
15. Baens M, Steyls A, Dierlamm J, de Wolf-Peeters C, Marynen P. Structure of the MLT gene and molecular characterization of the genomic breakpoint junctions in the t (11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type. Genes Chromosomes Cancer 2000;29:281-91.
16. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y et al. Resistance of t (11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001;357:39-40.
17. Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001;98:1182-7.
18. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122:1286-94.
19. Blazquez M, Haioun C, Chaumette MT, Gaulard P, Reyes F, Soule JC et al. Low grade B-cell mucosa associated lymphoid tissue lymphoma of the stomach: clinical and endoscopic features, treatment, and outcome. Gut 1992;33:1621-5.
20. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas. Strahlentherapie 1977;153:218-21.
21. Savio A, Franzin G, Wotherspoon AC, Zamboni G, Negrini R, Buffoli F et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 1996;87:1255-60.
22. Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-5.
23. Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997;26:527-37.
24. Montalban C, Manzanal A, Boixeda D, Redondo C, Alvarez I, Calleja JL et al. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies. Ann Oncol 1997;8:37-9.
25. Nobre-Leitao C, Lage P, Cravo M, Cabecadas J, Chaves P, Alberto-Santos A et al. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography. Am J Gastroenterol 1998;93:732-6.
26. Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999;131:88-95.
27. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001;48:297-303.
28. Levy M, Copie-Bergman C, Traulle C, Lavergne-Slove A, Brousse N, Flejou JF, et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 2002;97:292-7.
29. Caletti G, Ferrari A, Brocchi E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993;113:14-27.
30. Palazzo L, Roseau G, Ruskone-Fourmestraux A, Rougier P, Chaussade S, Rambaud JC et al. Endoscopic ultrasonography in the local staging of primary gastric lymphoma. Endoscopy 1993;25:502-8.
31. Levy M, Hammel P, Lamarque D, Marty O, Chaumette MT, Haioun C et al. Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest Endosc 1997;46:328-33.
32. Sackmann M, Morgner A, Rudolph B, Neubauer A, Thiede C, Schulz H et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 1997;113:1087-90.
33. Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdorfer E et al. Translocation t (11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 2000;95:4014-5.
34. Morgner A, Bayerdorffer E, Neubauer A, Stolte M. Helicobacter pylori associated gastric B-cell MALT lymphoma: predictive factors for regression. Gut 2001;48:290-2.
35. Thiede C, Wundisch T, Alpen B, Neubauer B, Morgner A, Schmitz M et al. Long-term persistence of monoclonal B-cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001;19:1600-9.
36. Fischbach W, Goebeler-Kolve M, Starostik P, Greiner A, Muller-Hermelink HK. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 2002;360:547-8.
37. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998;16:1916-21.
38. Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 2001;50:1258-64.
39. Cavicchi M, Lévy M, Lamarque D, Lahoud S, Haioun C, Hammel P et al. Suivi à long terme d'une cohorte de patients présentant un lymphome gastrique du MALT de bas grade traités par agents alkylants oraux (abstract). Gastroenterol Clin Biol 2002;26:A147.
40. Kosmas C, Stamatopoulos K, Stavroyianni N, Tsavaris N, Papadaki T. Anti-CD20-based therapy of B-cell lymphoma: state of the art. Leukemia 2002;16:2004-15.
41. Chan AO, Chu KM, Yuen ST, Leung SY, Lam SK, Wong J. Synchronous gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma in association with Helicobacter pylori infection: comparing reported cases between the East and West. Am J Gastroenterol 2001;96:1922-4.
42. Morgner A, Miehlke S, Stolte M, Neubauer A, Alpen B, Thiede C et al. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B-cell lymphoma of MALT type. World J Gastroenterol 2001;7:248-53.
43. Lamarque D, Lévy M, Roudot-Thoraval F, Copie-Bergman C, Cavicchi M, Auroux J et al. Développement rapide de l'atrophie et de la métaplasie intestinale dans la muqueuse gastrique en cas de lymphome du MALT (abstract). Gastroenterol Clin Biol 2002;26:A111.